JAGSNPHARM Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > jagsnpharm

Technical Analysis

Technical Strength: 8 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 54.4. According to RSI analysis, jagsnpharm is technically strong. 9.0 JAGSNPHARM RSI Chart
MACD (?) MACD: 0.899 and Signal Line: 0.855. According to MACD analysis, jagsnpharm is technically strong. 8.0 JAGSNPHARM MACD Chart
Simple Moving Average (?) According to simple moving average analysis, jagsnpharm is in a strong uptrend. Major support levels are 39.7075, 38.682, 31.32275. 10.0 JAGSNPHARM Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, jagsnpharm is in a strong uptrend. Major support levels are 40.15536, 38.7911, 33.31069. 10.0 JAGSNPHARM Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.637. 5.0 JAGSNPHARM Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above 61.8% and 50% level. Support is at 40.3 and 38.8368. Resistance level is 41.7632. 8.0 JAGSNPHARM Fibonacci Retracement Chart
Average True Range (?) ATR: 2.54 NA JAGSNPHARM Average True Range Chart
Average Directional Index (?) ADX is 17.2 which means JAGSNPHARM is in a trading range and there is no trend. NA JAGSNPHARM Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
October 21, 2020
Open Price 41.05
High Price 41.9
Low Price 40.3
Close Price 40.8
Absolute Change -0.25
Percentage Change -0.609%
Weekly Change -1.69%
Monthly Change 8.37%
Yearly Change 69.3%
52-week high 49.45
52-week low 16.25
Corporate Actions
ExDate Purpose
September 22, 2020 AGM/DIV-RS 0.50 PER SH
September 20, 2019 AGM/DIV-RS 0.25 PER SH
September 18, 2018 AGM/DIV-RE 0.10 PER SH
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.905
Confidence in Beta2.96%
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 21 October 2020: Deliverable Quantity:2.48e+04 NA JAGSNPHARM Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 21 October 2020: Daily Volatility:0.6954 NA JAGSNPHARM Annualized Daily Volatility (Spot Price) Chart

Announcements

September 07, 2020 Record Date Jagsonpal Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend & Meeting is 23-Sep-2020.
September 07, 2020 Book Closure Jagsonpal Pharmaceuticals Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 24-Sep-2020 to 30-Sep-2020 for the purpose of Dividend & Meeting.
See all Announcements

Board Meetings

Date Meeting Date Purpose
July 27, 2020 July 29, 2020 Financial Results/Dividend To consider and approve the financial results for the period ended March 31, 2020 and 30 June 2020 and dividend, if any
February 04, 2020 February 13, 2020 Financial Results To consider and approve the financial results for the period ended December 31, 2019
See all Board Meetings

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play